Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   SNARE mimicry by the CD225 domain of IFITM3 enables regulation of homotypic late endosome fusion
  2. Rahman, Kazi; Wilt,Isaiah; Jolley, Abigail A; Chowdhury,Bhabadeb; Datta, Siddhartha A K; Compton,Alex
  3. The EMBO Journal. 2024, Dec 09;
  1. 2.   Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22
  2. Ereño-Orbea, June; Liu, Xianglei; Sicard, Taylor; Kucharska, Iga; Li, Wei; Borovsky, Dorota; Cui, Hong; Feng,Yang; Dimitrov, Dimiter S; Julien, Jean-Philippe
  3. The Journal of biological chemistry. 2021, Aug; 297(2): 100966.
  1. 3.   Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence
  2. Ramakrishna, Sneha; Highfill, Steven L.; Walsh, Zachary; Nguyen, Sang M.; Lei, Haiyan; Shern, Jack F.; Qin, Haiying; Kraft, Ira L.; Stetler-Stevenson, Maryalice; Yuan, Constance M.; Hwang, Jennifer D.; Feng,Yang; Zhu, Zhongyu; Dimitrov, Dimiter; Shah, Nirali N.; Fry, Terry J.
  3. CLINICAL CANCER RESEARCH. 2019, Sep 1; 25(17): 5329-5341.
  1. 4.   5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox
  2. Müller, Fabian; Cunningham, Tyler; Stookey, Stephanie; Tai, Chin-Hsien; Burkett, Sandra; Jailwala, Parthav; Stetler Stevenson, Maryalice; Cam, Margaret C; Wayne, Alan S; Pastan, Ira
  3. Proceedings of the National Academy of Sciences of the United States of America. 2018, Feb 20; 115(8): E1867-E1875.
  1. 5.   Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv
  2. Loomis, K.; Smith, B.; Feng, Y.; Garg, H.; Yavlovich, A.; Campbell-Massa, R.; Dimitrov, D. S.; Blumenthal, R.; Xiao, X. D.; Puri, A.
  3. Experimental and Molecular Pathology. 2010, Apr; 88(2): 238-249.
  1. 6.   Identification and characterization of fully human anti-CD22 monoclonal antibodies
  2. Xiao, X.; Ho, M.; Zhu, Z.; Pastan, I.; Dimitrov, D. S.
  3. Mabs. 2009, May-Jun; 1(3): 297-303.
  1. 7.   Efficient killing of CD22(+) tumor cells by a humanized diabody-RNase fusion protein
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Seeber, S.; Rybak, S. M.
  3. Biochemical and Biophysical Research Communications. 2005, JUN 3; 331(2): 595-602.
  1. 8.   A dimeric angiogenin immunofusion protein mediates selective toxicity towards CD22(+) tumor cells
  2. Arndt, M. A. E.; Krauss, J.; Vu, B. K.; Newton, D. L.; Rybak, S. M.
  3. Journal of Immunotherapy. 2005, MAY-JUN; 28(3): 245-251.
  1. 9.   Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers
  2. Arndt, M. A. E.; Krauss, R.; Rybak, S. M.
  3. Febs Letters. 2004, DEC 17; 578(3): 257-261.
  1. 10.   Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment
  2. Krauss, J.; Arndt, M. A. E.; Martin, A. C. R.; Liu, H. T.; Rybak, S. M.
  3. Protein Engineering. 2003 16(10): 753-759.
  1. 11.   Generation of a highly stable, internalizing anti-CD22 single- chain Fv fragment for targeting non-Hodgkin's lymphoma
  2. Arndt, M. A. E.; Krauss, J.; Schwarzenbacher, R.; Vu, B. K.; Greene, S.; Rybak, S. M.
  3. International Journal of Cancer. 2003 107(5): 822-829.
  1. 12.   Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents: A new generation of therapeutics
  2. Hursey, M.; Newton, D. L.; Hansen, H. J.; Ruby, D.; Goldenberg, D. M.; Rybak, S. M.
  3. Leukemia & Lymphoma. 2002 43(5): 953-959.
  1. 13.   Antibody targeted therapeutics for lymphoma: new focus on the CD22 antigen and RNA
  2. Newton, D. L.; Rybak, S. M.
  3. Expert Opinion on Biological Therapy. 2001 1(6): 995-1003.
  1. 14.   Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2
  2. Paul, S. P.; Taylor, L. S.; Stansbury, E. K.; McVicar, D. W.
  3. Blood. 2000 96(2): 483-490.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel